676135-18-5 Usage
General Description
1-(3-Bromophenyl)-1-methylethylamine hydrochloride is a chemical compound with significant research interest. This molecule consists of a bromophenyl group, an ethylamine group, and a chloride ion, making it a type of organobromine compound, a class of molecules widely used in medical and scientific research. While the exact properties and potential uses may heavily rely on the context of the study, it is noted that such molecules frequently engage as precursors or intermediate compounds in the synthesis of more complex compounds. Adequately handled and stored, this component has proven its utility in laboratory settings for research purposes.
Check Digit Verification of cas no
The CAS Registry Mumber 676135-18-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,6,1,3 and 5 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 676135-18:
(8*6)+(7*7)+(6*6)+(5*1)+(4*3)+(3*5)+(2*1)+(1*8)=175
175 % 10 = 5
So 676135-18-5 is a valid CAS Registry Number.
InChI:InChI=1/C9H12BrN.ClH/c1-9(2,11)7-4-3-5-8(10)6-7;/h3-6H,11H2,1-2H3;1H
676135-18-5Relevant articles and documents
Facile synthesis of the glucosylceramide synthase inhibitor GZ667161
Hewlett, Elizabeth D.,Melenski, Edward,Qiu, Frederick V.,Leung, Hiu T.,Jacobson, Marlene,Qiu, Feng,Abou-Gharbia, Magid,Childers, Wayne
, (2020/09/10)
GZ667161 (GZ-161) is a quinuclidine-based small molecule inhibitor of the lysosomal enzyme glucosylceramide synthase. It represents an important tool molecule for studying the contribution of glycosphingolipids to disease pathology in lysosomal storage di
Glucosylceramide synthase inhibitors
-
Page/Page column 50, (2015/09/28)
The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, and for the treatment of cancer.
